(R)-4-CYCLOHEXYL-2-(PYRIDIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 1g

2-(2,6-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 100mg

C -(1,3-Diphenyl-1 H -pyrazol-4-yl)-methylamine, 95.0%, 100mg

4-Propargylthiomorpholine 1,1-Dioxide>98.0%(GC)25g

(3S,4R)-4-(BOC-AMINO)-3-FLUOROPIPERIDINE, 95.0%, 100mg

(9aS)-octahydro-1H-pyrido[1,2-a]piperazine; oxalic acid, 95.0%, 10g

(2-Chloropyridin-4-yl)(3,4-dimethylphenyl)methanone, 95%, 1g

(R)-4-Methyl-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide, 97%, 1g

(S)-3-Amino-4-(4-(trifluoromethyl)phenyl)butanoic acid hydrochloride, 95.0%, 1g

Persolfato di sodio 99 +%, puro 25 chilogrammi

4-(5-Nitro-6-pyrrolidin-1-yl-4-trifluoromethyl-pyridin-2-yl)-morpholine, 95.0%, 100mg

Imbuti filtranti Micro, 1 (100 – 160 μm), 1 pezzo

1-(1,3,4-OXADIAZOL-2-YL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 250mg